Despite these limitations, this study sufficiently analyzes the potential of [125I]α-Bgtx as a PET imaging agent binding to α7 nAChRs in the HP-SUB regions of postmortem human AD and CN subjects. Here, CHRNA7 is linked to Alzheimer disease.